Latest / Healthcare Mysteries Uncovered
Patient One: How an MDMA Trial Broke a Champion and a Field
Patient One: How an MDMA Trial Broke a Champion and a Field
Fear and trust were chemically altered in a clinical setting where rules failed: the lead therapist had no active license, his wife surrendered hers, and Patient One’s testimony was read by proxy at the FDA hearing that denied approval in August 2024. How did a phase two MDMA-assisted psychotherapy trial intended to treat treatment-resistant PTSD become the case that changed an entire field?
In this episode, we present the timeline and key facts of the MAPS MDMA trial involving Meaghan Buisson, showing who was involved, what happened…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.